Figure 4a reported the CD46 expression analysis on fresh BM MNCs from one representative MM patient (CD138+ MFICD46 = 2232.43; CD14+ MFICD46 = 1345.57; CD3+ MFICD46 = 552.32; CD56+CD138− MFICD46 = 463.46; CD19+ MFICD46 = 273.84). Here, CD19 is linked to Miyoshi myopathy.